ROS-Responsive Chitosan Coated Magnetic Iron Oxide Nanoparticles as Potential Vehicles for Targeted Drug Delivery in Cancer Therapy
Received 11 February 2020
Accepted for publication 18 April 2020
Published 12 May 2020 Volume 2020:15 Pages 3333—3346
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Prof. Dr. Anderson Oliveira Lobo
Srinivasan Ayyanaar,1 Chandrasekar Balachandran,2 Rangaswamy Chinnabba Bhaskar,3 Mookkandi Palsamy Kesavan,4 Shin Aoki,2,5 Ramachandran Palpandi Raja,6 Jegathalaprathaban Rajesh,7 Thomas J Webster,8 Gurusamy Rajagopal1
1PG and Research Department of Chemistry, Chikkanna Government Arts College, Tiruppur 641 602, Tamilnadu, India; 2Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda 278-8510, Japan; 3Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India; 4Department of Chemistry, Hajee Karutha Rowther Howdia College, Uthamapalayam 625 533, Tamil Nadu, India; 5Research Institute of Science and Technology, Tokyo University of Science, Noda 278-8510, Japan; 6Centre for Biotechnology, Anna University, Chennai 600 025, Tamil Nadu, India; 7Chemistry Research Centre, Mohamed Sathak Engineering College, Kilakarai 623 806, Tamil Nadu, India; 8Department of Chemical Engineering, Northeastern University, Boston, MA 02115, USA
Correspondence: Jegathalaprathaban Rajesh; Thomas J Webster Email firstname.lastname@example.org; email@example.com
Background and Objective: Cancer cells accumulate high concentrations of reactive oxygen species as a result of their faster and uninhibited metabolic activity. Cancer chemotherapeutic agents release an excess of severe adverse reactions as a result of targeting normal cells. This demands an improvement in targeted drug-delivery systems to selectively discharge anticancer drugs in the vicinity of such highly metabolically and mitotically active cells.
Materials and Methods: Here, magnetic nanoparticles were synthesized by a traditional co-precipitation technique. Fe3O4@OA-CS-5-FLU-NPs were synthesized by an easy and rapid in situ loading method. The proposed Fe3O4@OA-CS-5-FLU-NPs were productively prepared as well as characterized by various spectroscopic and microscopic studies.
Results: The targeted drug release profile of the Fe3O4@OA-CS-5-FLU-NPs was studied in the presence of ROS including H2O2 and pH induction. The released product, Fe3O4@OA-CS-5-FLU-NP, exhibited desirable levels of cytotoxicity and demonstrated morphological changes and inhibition of colony formation for A549 and HeLa S3 cancer cells. The IC50 values at 24 hours were 12.9 and 23 μg/mL, respectively.
Conclusion: In summary, results from the MTT assay, fluorescence staining as well as colony formation assays, revealed that the Fe3O4@OA-CS-5-FLU-NPs were active and safe for anticancer biomedical applications. In summary, the present investigation provides a powerful nanostructured based system for improved cancer theranostics that should be further studied.
Keywords: magnetic iron oxide nanoparticles, oleic acid, chitosan, 5-fluorouracil, cytotoxicity, targeted drug delivery